marketcaparena

VRCA

Verrica Pharmaceuticals Inc.

Company overview

Market capitalization
$79.02M
Employees
76
Latest publication
2026-09-29
About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Revenue5,862,000USD5,023,000USD5,092,000USD14,344,000USD12,702,000USD3,439,000USD344,000USD-1,781,000USD
Research Development6,034,000USD3,860,000USD2,520,000USD2,205,000USD1,846,000USD2,284,000USD1,167,000USD2,405,000USD
Selling General Administrative10,349,000USD9,989,000USD8,548,000USD9,403,000USD8,852,000USD8,548,000USD6,183,300USD14,982,999USD
Total Operating Expenses18,959,000USD13,849,000USD10,637,000USD11,608,000USD10,698,000USD11,146,000USD11,129,000USD18,488,000USD
Operating Income-13,097,000USD-9,715,000USD-6,946,000USD1,627,000USD1,510,000USD-8,130,000USD-11,410,000USD-20,704,000USD
Total Other Income Expense Net-56,000USD33,000USD-1,128,000USD-1,901,000USD-1,306,000USD-1,612,000USD-4,792,000USD-2,156,000USD
Interest Income111,000USD201,000USD205,000USD159,000USD228,000USD337,000USD205,000USD221,000USD
Interest Expense164,000USD160,000USD1,314,000USD2,094,000USD2,131,000USD2,203,000USD2,349,000USD2,376,000USD
Net Income-13,153,000USD-9,682,000USD-8,074,000USD-274,000USD204,000USD-9,742,000USD-16,202,000USD-22,860,000USD
Cost Of Revenue—889,000USD1,401,000USD1,109,000USD494,000USD423,000USD625,000USD435,000USD
Gross Profit—4,134,000USD3,691,000USD13,235,000USD12,208,000USD3,016,000USD-281,000USD-2,216,000USD
Net Interest Income—41,000USD-1,109,000USD-1,935,000USD-1,903,000USD-1,866,000USD-2,144,000USD-2,155,000USD
Income Before Tax—-9,682,000USD-8,074,000USD-274,000USD204,000USD-9,742,000USD-16,202,000USD-22,860,000USD
Net Income From Continuing Ops—-9,682,000USD-8,074,000USD-274,000USD204,000USD-9,742,000USD-16,202,000USD-22,860,000USD
Ebit—-9,715,000USD-6,760,000USD1,820,000USD2,335,000USD-7,539,000USD-13,853,000USD-20,484,000USD
Ebitda—-9,521,000USD-6,570,000USD2,004,000USD2,534,000USD-7,331,000USD-13,600,000USD-20,142,000USD
Depreciation And Amortization—194,000USD190,000USD184,000USD199,000USD208,000USD253,000USD342,000USD
Reconciled Depreciation—194,000USD190,000USD184,000USD199,000USD208,000USD253,000USD342,000USD
Selling And Marketing Expenses——300,000USD——300,000USD3,695,700USD1,100,000USD
Income Tax Expense——————-296,724USD-342,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue35,577,000USD7,566,000USD5,124,000USD9,032,000USD12,000,000USD12,000,000USD0USD0USD
Cost Of Revenue3,441,000USD2,740,000USD746,000USD725,000USD472,000USD229,000USD257,199USD20,294USD
Gross Profit32,136,000USD4,826,000USD4,378,000USD8,307,000USD11,528,000USD-229,000USD-257,199USD-20,294USD
Research Development8,855,000USD11,840,000USD20,295,000USD12,198,000USD15,929,000USD15,673,000USD15,436,000USD12,826,000USD
Selling General Administrative35,220,000USD58,017,700USD47,301,500USD17,405,000USD26,979,000USD24,508,000USD14,644,000USD9,052,000USD
Total Operating Expenses44,075,000USD70,745,000USD70,137,000USD29,603,000USD42,436,000USD39,952,000USD30,080,000USD21,878,000USD
Operating Income-11,939,000USD-65,919,000USD-65,759,000USD-21,296,000USD-30,908,000USD-40,181,000USD-30,080,000USD-21,878,000USD
Interest Income929,000USD1,417,000USD2,234,000USD476,000USD123,000USD521,000USD1,877,000USD1,231,000USD
Interest Expense7,742,000USD9,412,000USD3,962,000USD2,172,000USD4,295,000USD3,033,000USD0USD0USD
Net Interest Income-6,813,000USD-7,995,000USD577,000USD-1,696,000USD-4,172,000USD-2,512,000USD1,877,000USD1,231,000USD
Income Before Tax-17,886,000USD-76,579,000USD-66,995,000USD-24,487,000USD-35,080,000USD-42,694,000USD-28,207,000USD-20,648,000USD
Net Income-17,886,000USD-76,579,000USD-66,995,000USD-24,487,000USD-35,080,000USD-45,497,000USD-27,950,000USD-20,648,000USD
Net Income From Continuing Ops-17,886,000USD-76,579,000USD-48,313,000USD-24,487,000USD-35,080,000USD-42,694,000USD-28,207,000USD-20,648,000USD
Ebit-10,144,000USD-67,167,000USD-63,033,000USD-22,315,000USD-30,785,000USD-39,661,000USD-30,080,000USD-20,648,000USD
Ebitda-9,363,000USD-65,898,000USD-62,197,000USD-21,597,000USD-30,313,000USD-39,432,000USD-29,823,000USD-20,627,706USD
Depreciation And Amortization781,000USD1,269,000USD836,000USD718,000USD472,000USD229,000USD257,000USD20,294USD
Reconciled Depreciation781,000USD1,269,000USD820,000USD718,000USD472,000USD229,000USD257,000USD20,000USD
Total Other Income Expense Net-5,947,000USD-10,660,000USD-1,236,000USD-3,191,000USD-4,172,000USD-2,513,000USD1,873,000USD1,230,000USD
Selling And Marketing Expenses—4,300USD3,500USD—————
Unclassified Operating Expenses——2,537,000USD—————
Income Tax Expense——668,105USD3,191,000USD3,823,000USD2,803,000USD-257,000USD1,230,000USD
Non Operating Income Net Other———-1,019,000USD123,000USD520,000USD1,873,000USD1,230,000USD
Net Income Applicable To Common Shares———-24,487,000USD-35,080,000USD-42,694,000USD-28,207,000USD-20,648,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets36,017,000USD38,786,000USD47,131,000USD40,896,000USD39,107,000USD42,178,000USD54,134,000USD32,927,000USD
Cash And Equivalents11,198,000USD———————
Total Current Assets32,639,000USD32,755,000USD42,539,000USD36,275,000USD36,781,000USD39,474,000USD51,179,000USD28,187,000USD
Other Current Assets2,619,000USD2,368,000USD4,759,000USD5,545,000USD1,492,000USD1,767,000USD2,310,000USD2,560,000USD
Other Non Current Assets638,000USD———————
Total Liabilities31,710,000USD———————
Total Current Liabilities22,442,000USD16,219,000USD16,437,000USD28,908,000USD29,222,000USD29,396,000USD29,012,000USD21,026,000USD
Total Stockholder Equity4,307,000USD16,055,000USD24,743,000USD-17,040,000USD-17,484,000USD-18,576,000USD-9,860,000USD-34,051,000USD
Total Equity Including Noncontrolling Interest4,307,000USD———————
Deferred Revenue1,335,000USD———————
Net Receivables10,939,000USD7,813,000USD5,397,000USD7,329,000USD17,371,000USD5,653,000USD77,000USD84,000USD
Inventory2,712,000USD1,974,000USD2,236,000USD2,304,000USD2,522,000USD2,459,000USD2,463,000USD2,584,000USD
Property Plant Equipment Net561,000USD1,663,000USD1,862,000USD1,891,000USD1,950,000USD2,328,000USD2,579,000USD4,202,000USD
Accounts Payable1,603,000USD2,193,000USD2,072,000USD1,585,000USD2,321,000USD1,443,000USD1,896,000USD966,000USD
Short Term Debt355,000USD744,000USD746,000USD13,159,000USD13,319,000USD13,469,000USD13,605,000USD1,161,000USD
Common Stock2,000USD2,000USD2,000USD1,000USD1,000USD9,000USD9,000USD5,000USD
Retained Earnings-347,748,000USD-334,595,000USD-324,913,000USD-316,839,000USD-316,565,000USD-316,769,000USD-307,027,000USD-290,825,000USD
Total Liab—22,731,000USD22,388,000USD57,936,000USD56,591,000USD60,754,000USD63,994,000USD66,978,000USD
Other Current Liab—12,251,000USD12,837,000USD12,600,000USD13,101,000USD14,484,000USD13,511,000USD18,899,000USD
Capital Stock—2,000USD2,000USD1,000USD1,000USD9,000USD9,000USD5,000USD
Other Assets—1USD————-483,000USD—
Cash—20,600,000USD30,147,000USD21,097,000USD15,396,000USD29,595,000USD46,329,000USD22,959,000USD
Cash And Short Term Investments—20,600,000USD30,147,000USD21,097,000USD15,396,000USD29,595,000USD46,329,000USD22,959,000USD
Current Deferred Revenue—1,030,999USD782,000USD1,564,000USD481,000USD———
Net Debt—-19,158,000USD-28,516,000USD14,640,000USD23,496,000USD12,838,000USD-390,000USD24,154,000USD
Short Long Term Debt Total—1,442,000USD1,631,000USD35,737,000USD38,892,000USD42,433,000USD45,939,000USD47,113,000USD
Property Plant Equipment Gross—1,663,000USD2,912,000USD2,925,000USD3,055,000USD3,638,000USD3,837,000USD5,467,000USD
Common Stock Shares Outstanding—10,652,367shares10,652,367shares9,490,083shares9,490,600shares9,483,734shares6,732,599shares4,680,542shares
Non Current Assets Total—6,030,999USD4,592,000USD4,621,000USD2,326,000USD2,704,000USD2,955,000USD4,740,000USD
Non Current Liabilities Total—6,512,000USD5,951,000USD29,028,000USD27,369,000USD31,358,000USD34,982,000USD45,952,000USD
Non Current Liabilities Other—5,814,000USD5,066,000USD4,688,000USD————
Non Currrent Assets Other—4,103,999USD2,730,000USD2,730,000USD376,000USD376,000USD376,000USD538,000USD
Net Working Capital—17,910,000USD26,102,000USD7,367,000USD7,559,000USD10,078,000USD22,167,000USD7,161,000USD
Unclassified Equity—350,646,000USD349,652,000USD299,797,000USD299,079,000USD298,175,000USD297,149,000USD256,764,000USD
Short Long Term Debt———12,458,000USD12,673,000USD12,821,000USD12,938,000USD—
Long Term Debt———21,619,000USD24,578,000USD27,809,000USD30,983,000USD43,305,000USD
Unclassified Current Liabilities———-12,458,000USD-12,673,000USD-12,821,000USD-12,938,000USD—
Unclassified Non Current Liabilities———2,721,000USD2,791,000USD3,549,000USD3,999,000USD2,647,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets47,131,000USD54,134,000USD81,597,000USD44,721,000USD80,125,000USD74,154,000USD68,424,000USD91,906,000USD
Other Current Assets4,759,000USD2,310,000USD2,545,000USD4,355,000USD3,974,000USD2,180,000USD2,966,000USD1,343,000USD
Total Liab22,388,000USD63,994,000USD61,834,000USD4,688,000USD47,520,000USD41,168,000USD3,409,000USD2,477,000USD
Total Stockholder Equity24,743,000USD-9,860,000USD19,763,000USD40,033,000USD32,605,000USD32,986,000USD65,015,000USD89,429,000USD
Other Current Liab12,837,000USD13,511,000USD13,860,000USD2,655,000USD3,266,000USD3,114,000USD2,036,000USD1,517,000USD
Common Stock2,000USD9,000USD4,000USD4,000USD3,000USD3,000USD3,000USD3,000USD
Capital Stock2,000USD9,000USD4,000USD4,000USD3,000USD3,000USD3,000USD3,000USD
Retained Earnings-324,913,000USD-307,027,000USD-230,448,000USD-163,453,000USD-138,966,000USD-103,886,000USD-61,192,000USD-33,083,000USD
Cash30,147,000USD46,329,000USD69,547,000USD34,273,000USD15,752,000USD10,686,000USD9,241,000USD10,271,000USD
Cash And Short Term Investments30,147,000USD46,329,000USD69,547,000USD34,273,000USD70,354,000USD65,470,000USD62,017,000USD89,809,000USD
Total Current Assets42,539,000USD51,179,000USD77,530,000USD39,115,000USD74,328,000USD67,650,000USD64,983,000USD91,152,000USD
Total Current Liabilities16,437,000USD29,012,000USD17,024,000USD3,459,000USD46,055,000USD39,475,000USD3,351,000USD2,477,000USD
Current Deferred Revenue782,000USD————500,000USD——
Net Debt-28,516,000USD-390,000USD-24,037,000USD-32,747,000USD27,657,000USD26,520,000USD-9,053,000USD-10,271,000USD
Short Term Debt746,000USD13,605,000USD700,000USD297,000USD41,944,000USD35,513,000USD130,000USD—
Short Long Term Debt Total1,631,000USD45,939,000USD45,510,000USD1,526,000USD43,409,000USD37,206,000USD188,000USD—
Net Receivables5,397,000USD77,000USD4,416,000USD487,000USD0USD———
Inventory2,236,000USD2,463,000USD1,022,000USD-487,000USD————
Accounts Payable2,072,000USD1,896,000USD2,464,000USD507,000USD845,000USD348,000USD1,185,000USD960,000USD
Property Plant Equipment Net1,862,000USD2,579,000USD3,615,000USD5,330,000USD5,502,000USD4,938,000USD2,201,000USD255,000USD
Property Plant Equipment Gross2,912,000USD3,837,000USD4,789,000USD6,029,000USD5,756,000USD4,938,000USD2,201,000USD255,000USD
Common Stock Shares Outstanding10,652,367shares5,180,822shares4,534,245shares3,416,343shares2,704,446shares2,499,555shares2,489,788shares2,485,282shares
Non Current Assets Total4,592,000USD2,955,000USD4,067,000USD5,606,000USD5,797,000USD6,504,000USD3,441,000USD754,000USD
Non Current Liabilities Total5,951,000USD34,982,000USD44,810,000USD1,229,000USD1,465,000USD1,693,000USD58,000USD0USD
Non Current Liabilities Other5,066,000USD——1,229,000USD1,465,000USD1,693,000USD58,000USD—
Non Currrent Assets Other2,730,000USD376,000USD452,000USD276,000USD295,000USD1,566,000USD1,240,000USD499,000USD
Net Working Capital26,102,000USD22,167,000USD60,506,000USD35,656,000USD28,273,000USD28,175,000USD61,632,000USD88,675,000USD
Unclassified Equity349,652,000USD297,149,000USD250,203,000USD203,478,000USD171,594,000USD136,865,000USD126,181,000USD122,523,000USD
Short Long Term Debt—12,938,000USD——41,693,000USD35,315,000USD——
Long Term Debt—30,983,000USD42,874,000USD——35,315,000USD——
Unclassified Current Liabilities—-12,938,000USD——-41,693,000USD-35,315,000USD——
Unclassified Non Current Liabilities—3,999,000USD1,936,000USD——-41,268,000USD——
Other Assets——1USD276,000USD295,000USD1,566,000USD1,240,000USD499,000USD
Accumulated Other Comprehensive Income——0USD—-29,000USD1,000USD20,000USD-17,000USD
Short Term Investments———0USD54,602,000USD54,784,000USD52,776,000USD79,538,000USD
Net Tangible Assets———40,033,000USD32,605,000USD32,986,000USD65,015,000USD89,429,000USD
Deferred Long Term Liab—————100,000USD——
Other Liab—————5,853,000USD——
Unclassified Non Current Assets—————-1,566,000USD-1,240,000USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-9,682,000USD-8,074,000USD-274,000USD204,000USD-9,742,000USD-16,202,000USD-22,860,000USD-17,186,000USD
Depreciation194,000USD174,000USD184,000USD118,000USD208,000USD253,000USD342,000USD334,000USD
Stock Based Compensation897,000USD686,000USD718,000USD888,000USD1,026,000USD756,000USD2,108,000USD2,228,000USD
Other Non Cash Items2,345,000USD615,000USD1,124,000USD353,000USD417,000USD3,220,000USD832,000USD657,000USD
Change To Account Receivables-2,416,000USD1,932,000USD10,042,000USD-11,718,000USD-5,559,000USD-146,000USD10,277,000USD-2,615,000USD
Change To Inventory262,000USD-159,000USD218,000USD-59,000USD0USD—0USD—
Change In Working Capital-2,020,000USD2,008,000USD7,933,000USD-11,607,000USD-4,586,000USD-4,091,000USD11,020,000USD-2,391,000USD
Total Cash From Operating Activities-9,163,000USD-4,591,000USD9,685,000USD-10,044,000USD-12,677,000USD-16,064,000USD-8,558,000USD-16,358,000USD
Capital Expenditures0USD0USD0USD0USD0USD0USD-16,000USD-11,000USD
Free Cash Flow-9,163,000USD-4,591,000USD9,685,000USD-10,044,000USD-12,677,000USD-16,064,000USD-8,574,000USD-16,369,000USD
Net Borrowings-111,000USD-36,006,000USD-3,984,000USD-4,155,000USD-4,057,000USD-1,514,000USD-217,000USD—
Total Cash From Financing Activities-120,000USD13,641,000USD-3,984,000USD-4,155,000USD-4,057,000USD39,426,000USD-397,000USD-640,000USD
Change In Cash-9,547,000USD9,050,000USD5,701,000USD-14,199,000USD-16,734,000USD23,370,000USD-8,971,000USD-17,009,000USD
Begin Period Cash Flow30,147,000USD21,097,000USD15,396,000USD29,595,000USD46,329,000USD22,959,000USD31,930,000USD48,939,000USD
End Period Cash Flow20,600,000USD30,147,000USD21,097,000USD15,396,000USD29,595,000USD46,329,000USD22,959,000USD31,930,000USD
Other Cashflows From Financing Activities-120,000USD-420,000USD-3,984,000USD—-3,959,000USD1,303,000USD662,000USD-613,000USD
Unclassified Financing Cash Flow—50,067,000USD3,984,000USD—3,959,000USD———
Investments——0USD——8,000USD-16,000USD-11,000USD
Total Cashflows From Investing Activities—————8,000USD-16,000USD-11,000USD
Issuance Of Capital Stock—————39,637,000USD0USD0USD
Other Cashflows From Investing Activities—————8,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-17,886,000USD-76,579,000USD-66,995,000USD-24,487,000USD-35,080,000USD-42,694,000USD-28,207,000USD-20,648,000USD
Depreciation429,000USD1,269,000USD836,000USD718,000USD472,000USD229,000USD257,199USD20,000USD
Stock Based Compensation3,318,000USD7,164,000USD14,376,000USD4,985,000USD6,053,000USD9,821,000USD3,333,000USD2,251,000USD
Other Non Cash Items2,764,000USD5,192,000USD3,347,000USD1,934,000USD1,442,000USD802,000USD2,269,800USD-435,000USD
Change To Account Receivables-5,320,000USD4,339,000USD-3,929,000USD-487,000USD-487,000USD410,000USD-487,000USD—
Change In Working Capital-6,252,000USD2,027,000USD9,859,000USD-1,800,000USD-535,000USD1,635,000USD-1,728,000USD938,000USD
Total Cash From Operating Activities-17,627,000USD-60,927,000USD-38,577,000USD-18,650,000USD-27,582,000USD-30,207,000USD-27,408,000USD-17,874,000USD
Capital Expenditures0USD-27,000USD-362,000USD-302,000USD-883,000USD-1,470,000USD-682,000USD-774,000USD
Free Cash Flow-17,627,000USD-60,954,000USD-38,939,000USD-18,952,000USD-28,465,000USD-31,677,000USD-28,090,000USD-18,648,000USD
Net Borrowings-48,202,000USD-2,064,000USD44,082,000USD-43,767,000USD4,975,000USD34,460,000USD34,460,000USD34,460,000USD
Total Cash From Financing Activities1,445,000USD37,728,000USD74,213,000USD-16,870,000USD33,646,000USD35,232,000USD423,000USD99,376,000USD
Issuance Of Capital Stock50,067,000USD39,637,000USD30,301,000USD26,901,000USD28,118,000USD0USD0USD107,250,000USD
Change In Cash-16,182,000USD-23,218,000USD35,274,000USD18,521,000USD5,066,000USD1,445,000USD-1,030,000USD1,608,000USD
Begin Period Cash Flow46,329,000USD69,547,000USD34,273,000USD15,752,000USD10,686,000USD9,241,000USD10,271,000USD8,663,000USD
End Period Cash Flow30,147,000USD46,329,000USD69,547,000USD34,273,000USD15,752,000USD10,686,000USD9,241,000USD10,271,000USD
Other Cashflows From Financing Activities-420,000USD155,000USD-169,000USD-17,000USD558,000USD410,000USD423,000USD21,000,000USD
Investments—-19,000USD6,619,000USD54,523,000USD86,000USD-1,889,000USD27,861,000USD-79,120,000USD
Total Cashflows From Investing Activities—-19,000USD-362,000USD54,041,000USD-998,000USD-3,580,000USD25,955,000USD-79,894,000USD
Other Cashflows From Investing Activities—8,000USD—-180,000USD-201,000USD-221,000USD-1,224,000USD-499,000USD
Unclassified Investing Cash Flow——-6,619,000USD—————
Change To Inventory———487,000USD————
Change To Liabilities———-593,000USD205,000USD-338,000USD12,000USD1,861,000USD
Sale Purchase Of Stock———26,901,000USD28,676,000USD453,000USD423,000USD78,376,000USD
Cash And Cash Equivalents Changes———18,521,000USD5,066,000USD1,445,000USD-1,030,000USD1,608,000USD
Unclassified Operating Cash Flow——————-3,332,999USD—
Unclassified Financing Cash Flow——————-34,883,000USD-34,460,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30ProductLicense And Collaboration Revenue769,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductProduct5,093,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductLicense And Collaboration Revenue733,000USD0001660334-26-000014
Q1 2026Quarterly · 2026-03-31ProductProduct4,290,000USD0001660334-26-000014
Q4 2025Quarterly · 2025-12-31ProductLicense And Collaboration Revenue1,370,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductProduct3,722,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductLicense And Collaboration Revenue20,292,000USD0001660334-26-000008
FY 2025Yearly · 2025-12-31ProductProduct15,285,000USD0001660334-26-000008
Q3 2025Quarterly · 2025-09-30ProductLicense And Collaboration Revenue10,737,000USD0001660334-25-000006
Q3 2025Quarterly · 2025-09-30ProductProduct3,607,000USD0001660334-25-000006
Q2 2025Quarterly · 2025-06-30ProductLicense And Collaboration Revenue8,168,000USD0000950170-25-107358
Q2 2025Quarterly · 2025-06-30ProductProduct4,534,000USD0000950170-25-107358
Q1 2025Quarterly · 2025-03-31ProductLicense And Collaboration Revenue17,000USD0001660334-26-000014
Q1 2025Quarterly · 2025-03-31ProductProduct3,422,000USD0001660334-26-000014
FY 2024Yearly · 2024-12-31ProductLicense And Collaboration Revenue992,000USD0001660334-26-000008
FY 2024Yearly · 2024-12-31ProductProduct6,574,000USD0001660334-26-000008
Q2 2024Quarterly · 2024-06-30ProductLicense And Collaboration Revenue285,000USD0000950170-25-107358
Q2 2024Quarterly · 2024-06-30ProductProduct4,892,000USD0000950170-25-107358
Q1 2024Quarterly · 2024-03-31ProductCollaboration594,000USD0000950170-25-070452
Q1 2024Quarterly · 2024-03-31ProductProduct3,232,000USD0000950170-25-070452
FY 2023Yearly · 2023-12-31ProductCollaboration466,000USD0000950170-25-037172
FY 2023Yearly · 2023-12-31ProductProduct4,658,000USD0000950170-25-037172
FY 2022Yearly · 2022-12-31ProductCollaboration9,032,000USD0000950170-24-022659
FY 2022Yearly · 2022-12-31ProductProduct0USD0000950170-24-022659

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.